Saturday, December 16, 2017

Hemp’s ‘Double Crop’ Potential: Pennsylvania’s Research Program Is A Game Changer

By 
Source: dopemagazine.com

The Farm Bill was passed in 2014, which made it federally legal for institutions of higher education or state Departments of Agriculture to research the cultivation and marketing of industrial hemp. Fast forward to 2016’s Industrial Hemp Research Act, Number 92 in Pennsylvania—which launched the Industrial Hemp Research Pilot Program for the 2017 growing season—and we have the makings of a booming industry.
The pilot program is the first time hemp has legally grown in the commonwealth in 80 years, and in a year’s time it is expected to increase from just 50 acres of crops to more than 5,000 in 2018. According to Agriculture Secretary Redding, farmers must figure out how to harvest the plant before Pennsylvania hemp can be sold for commercial use. “So what do you want? Do you want the fibrous stems? Do you really just want the seed heads? All of that was part of a conversation and exploration this past year,” he explained to National Public Radio station 90.5 WESA.
This is where research comes into play. The Industrial Hemp Research Pilot Program has focused on hemp variety comparison for suitability in Pennsylvania’s growing conditions, comparison of hemp’s capability for weed suppression to other crops, and the crops’ productivity in existing Pennsylvania farmland. According to Redding and current research, hemp could work as a double crop—when two different crops are grown on the same land in a single season. “Research . . . at Penn State (showed) that you can actually use industrial hemp as a double crop, behind wheat,” he noted to WESA. “I think if that plays out to be real, that is a game changer . . . You immediately change what options farmers have and you open up new markets.”
With these new developments, it’s no wonder Pennsylvania is set to increase acreage of industrial hemp one hundredfold in the next year. Researchers from institutions of higher education or individuals interested in being considered for participation in the growing 2018 program must submit an application to the Pennsylvania Department of Agriculture Industrial Hemp Research Pilot Program prior to January 19, 2018. Researchers who participated in the 2017 Pilot Program simply submit a renewal form and can continue their projects in the 2018 growing season.
Hemp's 'Double Crop' Potential: Pennsylvania's Research Program Is A Game Changer

Arkansas begins researching hemp with pilot program

Source: thv11.com

Image result for arkansas hemp

LITTLE ROCK, Ark. (KTHV) - After 80 years of prohibition, industrial hemp is legal again in Arkansas. The Arkansas State Plant Board is creating rules for a help research program that will begin next year.
Earlier this year, the Arkansas Industrial Hemp Act passed in legislation.
"Just to use a new crop that could bring in some money in the coming years as a rotation, it’s exciting," said Jeremy Fisher, V.P. of Arkansas Hemp Association.
Agriculture is the largest industry in Arkansas and now a new door is opening to farmers.
"It’s important to revive that to bring in a new rotation crop," said Fisher.
While hemp and marijuana products both come from the cannabis plant, hemp is different in its use, physical appearance and has a low amount of THC.
“It will not get you high," said Fisher.
President Obama signed the Agricultural Act of 2014 which allows universities and state agriculture departments to begin cultivating industrial hemp. At least 15 states enacted legislation this year, making more than half of the country on board with growing hemp.
The plant is used in more than 25,000 products including fibers, textiles, paper, construction, cosmetics and food.
"It’s going to help us transition into a new green economy in the future," said Nicholas Dial, President of the Arkansas Hemp Association.
Nicholas Dial and Jeremy Fisher helped draft Act 981 that legalized industrial hemp in the state. They founded the Arkansas Hemp Association in August.
Next Spring, the Arkansas State Plant Board will begin issuing licenses for growers, like farmers, for a 10 year industrial hemp research program. The research program will start small but is expected to steadily increase over the years as the crop proves it can be beneficial in the state.

Flooded hemp market could weigh on ND production

By Jessica Holdman
Source: bismarcktribune.com

hemp
Hemp grows in North Dakota in August 2016. As North Dakota's hemp industry soars, legal questions have kept producers from making one of the crop's most desirable derivatives.

North Dakota’s industrial hemp industry saw extensive growth in 2017 but an over supplied hemp seed market could impact North Dakota’s acres in the coming year.
The research program, run by the North Dakota Department of Agriculture, licensed 35 farmers to grow a total of 3,000 acres last year. The year prior the program had five growers with a total of 70 acres accepted into the program.
And Friday about 70 people, a group made up of previous and perspective growers, attended a meeting at the state Capitol to learn about production in the state.
“These are the people that are really serious about producing or processing,” Agriculture Commissioner Doug Goehring said.
Because of its botanical relationship to marijuana, hemp only can be legally grown through the department’s pilot program or by universities, provisions made possible by the 2014 Farm Bill.
Goehring doesn’t want to discourage growers but does aim to ensure there is enough demand from processors to support the number of acres planted in the state.
“I’ll continue to expand the number of acres permitted if producers have the opportunity to sell product,” he said earlier this year. “If I’m going to permit 20,000 acres, I’m going to check with processors to make sure they’re able to handle it.”
As $2.58 per bushel corn is causing financial hurt to farmers, Goehring doesn’t want to put hemp farmers in a similar position. Hemp is complicated further by the logistics of storing the harvested seed, which falls under the U.S. Drug Enforcement Administration’s schedule 1 controlled substance category, while waiting for supply to go down and price to go up.
Goehring said he has been working on a market analysis with processors in the state, of which there are now two — Healthy Oilseeds in Carrington and, as of a couple weeks ago, Anchor Ingredients near Fargo. He expects to have a better idea about allowable acres in late January.
Applications for planting industiral hemp in the state can be filed at www.nd.gov/ndda/plant-industries/industrial-hemp. The deadline for proposal documents is 5 p.m. Dec. 29. Emailed or faxed submissions will not be accepted. For more information contact Rachel Seifert-Spilde at 701-328-4128 or rseifert@nd.gov.

Fifth Annual NoCo Hemp Expo Brings Together Hemp Industry

By Theresa Rose
Source: northfortynews.com



World’s largest gathering of industrial hemp producers takes place at the 5th Annual NoCo Hemp Expo, April 6 – 7, 2018, at the Ranch Events Complex in Loveland, CO; Call for speakers, sponsor, exhibitors is now live.
Loveland, CO (December 13, 2017) –Tickets are now on sale for the 5th Annual NoCo Hemp Expo, the largest two-day gathering of hemp thought leaders, speakers, producers, entrepreneurs, and exhibitors from around the globe. Taking place April 6-7, 2018, at the Ranch Events Complex in Loveland, CO, the event will showcase the latest products, innovations, research and advancements in the hemp industry world-wide.
Recognized by the Hemp Industries Association as the “Hemp Event of the Year,” NoCo5 will offer two interactive expo halls featuring products from international brands, introduce a Farm and Agriculture Symposium to share the latest research, techniques and methodologies for industrial hemp production, and an expanded hemp investment summit for the 5,500 attendees projected this year – an increase from 4,700 in 2017. The trade show and conference is considered the most influential hemp-centric event in North America.
The $2 billion hemp industry worldwide continues to gain increased attention. This year’s NoCo5 will draw professionals across industrial, nutritional and therapeutic hemp industries and feature attendance by state and federal government representatives spearheading current legislative changes around the future of hemp in the U.S. bringing increased media spotlights and attention on the future of the industry.
Bipartisan Support Grows for Industrial Hemp
With growing support across bipartisan lines, Congressman James Comer (R-KY)  Bob Goodlatte (R-VA), Jared Polis (D-CO), and Thomas Massie (R-KY)  joined forces to reintroduce the Industrial Hemp Farming Act in the summer of 2017 calling for the complete removal of hemp from its current oversight and regulations of the Controlled Substances Act.
“Hemp has boundless potential as a sustainable alternative to plastics and other environmentally harmful products,” said Polis. “It’s past time that we eliminate absurd barriers and allow hemp farmers to get to work, create jobs, and grow this promising and historically important crop.”
Industry B2B Day Focuses on Entrepreneurship, Investment and Consumer Markets
On Friday, April 6, NoCo5 is hosting “Industry B2B Day,” open to trade visitors and those interested in the hemp products market. Programming will feature the 3rd annual Hemp Summit, an important gathering of hemp-focused investors, founders and professionals. In addition, Industry B2B Day attendees are invited to visit the exhibition halls, participate in interactive demonstrations, attend panels from over 75 industry experts and speakers, and learn the latest in new technologies, techniques, and applications.
New to NoCo5: Agricultural and Farm Symposium
For agricultural producers, a new, full-day NoCo5 Agricultural and Farm Symposium on Saturday, April 7, will highlight early learnings, recommended production practices and market opportunities from pilot programs in Colorado, Kentucky, Pennsylvania and other states and regions where commercial hemp crops are permitted and/or licensed to be grown. The symposium also will feature new equipment, recommended growing practices, and farming and agricultural exhibits.
Consumer Day Features Global Hemp Village, Education and Two Expo halls
NoCo5’s two exhibition halls and educational seminars are open to the general public on Saturday, April 7, where attendees will sample and experience the latest usage of natural industry hemp products, and attend panels and speaking events on the latest in environmental impacts, nutrition, and growing health and wellness applications. In addition, the NoCo5 Global Hemp Village will showcase innovative products and ideas from international exhibitors, from super foods, supplements, textiles, paper, accessories, hemp beauty products, and plastic and building alternatives.
“The cultural shift in the perceptions, demand, and applications for hemp in the U.S. and around the world are priming the hemp industries for growth, and NoCo5 is at the epicenter of the industrial hemp revolution” says president and NoCo Hemp Expo co-founder Morris Beegle.
Tickets and Registration; Call for Speakers, Sponsors and Exhibitors
Tickets and registration are available for the General Public, Industry B2B Day (including the Hemp Business Summit), and the Agricultural and Farm Symposium athttp://nocohempexpo.com/ticket-sales/. For speaker, sponsor, exhibitor and volunteer inquiries, visit http://nocohempexpo.com/registration-noco5/.
About NoCo Hemp Expo
Now in its fifth year, NoCo Hemp Expo – NoCo5 – is produced by WAFBA LLC (We Are For Better Alternatives), based in Loveland, CO. Established in 2012, WAFBA is also founder ofTreeFreeHemp paper and printing services, and Colorado Hemp Company, “supporting all things hemp.” Areas of focus include product and brand development, marketing, printing, production, events and advocacy. Learn more at NocoHempExpo.com, and find us on Facebook and Twitter.
Contact:
Steven Hoffman, Compass Natural, tel 303.807.1042steve@compassnaturalmarketing.com


By Gretchen Lidicker
Source: mindbodygreen.com


CBD oil is gaining major traction in the wellness world, as people praise its ability to transform a person's sleep and temper anxiety. There are even hemp-infused topical products popping up on the market. But despite its growing popularity, there is still a lot of misinformation and even stigma associated with CBD. Will it get you high? Is it safe? Is it even legal?

It's important to know that CBD does not have any of the psychoactive effects associated with THC, which is found in high quantities in marijuana. Instead, CBD contains many of the healing properties—without "the high." CBD is generally considered safe and is legal in most states. That being said, it's always important to talk to your doctor about trying a new supplement and a lot more research is needed on the long-term use of CBD.

The existing information is super promising for various conditions ranging from insomnia to epilepsy to chronic pain. Not to mention, top integrative and functional medicine experts are getting behind this amazing natural chemical. Here's what excites the pros most about CBD, plus, how they're using it on themselves and their patients:



It can be the missing piece of the health puzzle.


"I have been using CBD on various patients at my functional medicine center for some time now, and we are loving the clinical results! I use it to support healthy balanced inflammation levels in people with autoimmunity, pain, and anxiety. For some, CBD has truly been the missing link in their health puzzle. It's one of the few things that I, too, take every day." —William Cole, D.C.



Photo: @bdspn


There's a lot of potential for chronic pain.

"Ultimately there is a role for CBD in a variety of conditions. It decreases anxiety, is anti-inflammatory, and can help with sleep. It does also have some positive impact on pain. Some of it may be for the reasons I listed above. It doesn’t have the psychotropic effects of THC, and it is legal (for now). The tricky part is that we don’t have robust studies fully clarifying dose, interactions, and contraindications. I do have patients who anecdotally find that it is helpful when used topically for arthritis and orally (spray) for pain. I think often it is beneficial because it helps with sleep and anxiety, which both can be an issue with both acute and chronic pain. I have other patients who have no response." —Carrie Diulus, M.D.


I'm wary of recommending it before more research is done.
"Recently a lot of patients have asked me about CBD oil, which seems to reflect a growing interest in CBD oil nationwide as a remedy for many different ailments. While many people have told me individually that they have gained a lot of personal pain/anxiety/depression/psychosis relief from the use of CBD oil, research is still ongoing and has not definitively determined either clear benefits or harm. There is definitely some interesting research that is being conducted on the treatment of psychosis with CBD oil. I am wary of recommending CBD oil at this point for these reasons and also because there has not been much regulation of the product, which is concerning when I want to make sure that my patients are getting a safe product." —Aparna Iyer, M.D.



It looks promising for a ton of health ailments, but talk to your doctor first.


"CBD varies per concentration, so getting a reliable brand and source is key. It doesn’t alter the person's state of mind who uses it like marijuana does, but it does produce many positive changes and has many medical benefits including improving the immune system, being anti-inflammatory, improving mood, appetite, cognitive function, anxiety, depression, insomnia, addiction, epilepsy, improves cancer, Crohn's disease, and even acne. Physicians recommend it for their chronic pain patients as well as fibromyalgia and multiple sclerosis. Studies have shown the use of CBD oil in mice reducing inflammation significantly. Physicians also recommend CBD oil in patients who want to quit smoking as well as decrease opioid usage. It seems to be the wonder drug everyone wants! You can inhale it, rub in on the skin, or put drops in your food. My personal reservations for CBD oil are there are still no long-term safety data studies and studies haven’t been done in children yet. Some side effects include diarrhea and weight and appetite changes. Talk to your doctor if this is a good alternative and to see if CBD is right for you." —Bindiya Gandhi




A New Era Of Treatment: Medicinal Cannabis In India

by 
Source: businessworld.in



Cannabis is something which brings up many thoughts in the Indian mind. A subject of intense debate globally, cannabis is finding increasing acceptance in the medical community, with major developments abroad in terms of policy and society for accepting medicinal cannabis. With the use of cannabis for medical use thoroughly ingrained in the Indian Ayurveda and Atharvaveda system, it is high time that there is a consensus about its huge medicinal potential. In an exclusive interview with BW Businessworld, Dr. Arno Hazekamp, scientific advisor to Bombay Hemp Company (BOHECO) and global cannabis expert, Avnish Pandya, Director of Research and Development at BOHECO and Siddhant Mistry, Associate Scientist at BOHECO discuss the various facets of medicinal cannabis, its use in Indian medical history, its medicinal benefits and the policy changes in India set to take place with respect to medicinal cannabis. Edited excerpts: 

How deeply imbibed is the medicinal use of cannabis in Indian medical history? Why is it's medicinal use shunned in contemporary Indian society?
The cannabis plant has been used in India since the dawn of time, based on written sources and archeological findings. In old times, the plant was used not only for medicinal use but also for cultural, religious and spiritual reasons. Moreover, hemp seeds were a common, and nutritious, food. In short: cannabis played many roles for different groups of people. The medicinal use became increasingly shunned only in the 20th century, not only in India but worldwide. The reason was that cannabis has medicinal uses, but can also be used as a narcotic drug. When cannabis plants became more potent as a result of breeding and selection, and the medical use became more obsolete as a result of opiates and other modern drugs, there was no more practical need for cannabis. Since 1961, cannabis has been banned worldwide, including in India. In recent times, it has become clearer that opiates may be more dangerous than initially believed, while cannabis turns out to be more medicinally useful that believed. Now the medicinal use of cannabis is increasingly embraced by other countries, India can surely not stay behind to claim back one of its most authentic medicinal plants.
Can you briefly describe some of the proven medical uses of cannabis? What is the comparison between the medical properties of cannabinoids vs the medical properties of opioids in treating pain?
The problem with ‘proven’ medicinal effects is that such claims are based on the gold standard of modern clinical research: the placebo-controlled, double-blind, randomized clinical trial. Such trials have been hard to do over the last few decades, as a result of the cost (who is going to pay for such expensive trials when you can not patent the cannabis plant to be yours), and the lack of pharmaceutical grade cannabis in most countries. The lack of clinical trials does not reflect the fact it does not work, but it reflects how hard it is to set up and execute such trials. Nevertheless, studies are increasingly being done around the world, and the following effects of the main cannabis components THC and CBD are most proven, based on a recent meta-analysis.
There is conclusive or substantial evidence that cannabis or cannabinoids are effective:
• For the treatment of chronic pain in adults
• As antiemetics in the treatment of chemotherapy-induced nausea and vomiting
• For improving patient-reported multiple sclerosis spasticity symptoms
There is more moderate evidence that cannabis or cannabinoids are effective for:
• Improving short-term sleep outcomes in individuals with sleep disturbance associated with obstructive sleep apnea syndrome, fibromyalgia, chronic pain, and multiple sclerosis
• Increasing appetite and decreasing weight loss associated with HIV/AIDS
• Improving clinician-measured multiple sclerosis spasticity symptoms
• Improving symptoms of Tourette syndrome
• Improving anxiety symptoms, in individuals with social anxiety disorders
• Improving symptoms of posttraumatic stress disorder
Please note that THC and CBD have different therapeutic effects that can sometimes overlap and sometimes work synergistically.
Opiates have been gold standard for use in pain alleviation not only in the end of life care but also in a variety of other ailments. Over a period of time, the most abundant painkiller or analgesic to come to light has been opiates. Opium has been used so predominantly in the west and the upcoming eastern part of the world as a successful analgesic in the pharmaceutical industry where it is used abundantly till date for.
1. Reducing pain scores
2. Inducing sleep
3. Analgesic
Even though it fulfills the requirements of a painkiller the drawbacks/ side-effects during or post-treatment harbor potential negative consequences such as:
1. Opioid overdose morbidity
2. Opioid analgesic overdose mortality
3. Constipation
4. Physical dependence
The most common side effect of opiates are constipation and nausea.
As of today itself, opiates and its derivates cause the death of 91 American individuals daily due to opioid analgesic overdose morbidity. Hence we can conclude that, in the battle of Cannabinoids vs Opioids, Cannabinoids are safer analgesic as even at high concentration dosage and administration of Cannabinoids to humans does not cause death as compared to opiates which are also highly addictive. 
How can the recreational use of cannabis be separated from its medicinal use? What are the possible steps which can be taken in ending the stigma towards cannabis in India?
In countries that have experience with introducing medicinal cannabis, separation between medicinal and recreational markets is done by taking care of the following aspects:
1. Medicinal cannabis products are made and handled by official, certified parties only (cultivation, harvest, packaging, lab research, distribution). They have to take care of proper bookkeeping and security.
2. These products are available on prescription only, for patients who have a serious and well-documented illness.
3. Cannabis as a medicine is provided after regular medicines have been tried, but fail to have sufficient therapeutic effect.
4. Medicinal use is always done under the supervision of a physician or pharmacist.
5. The cost of medicinal cannabis is not much different from the price of the black market. If medicinal cannabis is too cheap it may be resold on the black market, if it is too expensive patients will search for cheaper materials on the black market.
6. Medicinal cannabis is quality controlled, meaning there are no contaminants present and the content of cannabinoids is always the same.
The first step in ending stigma in India, and any other country, is to make cannabis available for very sick patients, and palliative patients, first. It is much easier to accept cannabis medicines for severely ill patients, than just to introduce it for large groups all at once. Every society needs to get used to cannabis medicine after so many decades of prohibition. Give those who fear it some time to readjust and see for themselves it relieves suffering.
According to the Traditional Knowledge Digital Library and the Central Council for Research in Ayurvedic Sciences, what are the pharmacological properties of Cannabis?
According to the TKDl of India, Cannabis has been used over 1000 years in our Ayurveda and other alternative systems of Medicine like Unani and Siddha e.g the use of bhang and its formulation has been known for over 1000 years. In the TKDl the use of Cannabis has mainly been for its analgesic, anesthetic properties, and a resolvent. A very well-known property of Cannabis is also appetite stimulation. Within the TKDl, Cannabis is also present as a part of many formulations which are polyherbal and have been used since many years in India for medical purposes.
Within the CCRAS ambit, Cannabis has showcased the effect of a potent analgesic, antiemetic, appetite stimulant, sleep inducer, improves reproductive capacity, strengthens the GI tract, is a diuretic, helps in dysmenorrhea, cough as well as tuberculosis.
How can an age-old medicine such as cannabis be modernized in the Indian medical context? What has been the progress so far?
The difference between traditional medicine and modern medicine is mainly in the understanding of risks versus benefits, and in the certified quality of the products. The main elements are:
-modern medicinal cannabis should be standardized (always the same chemical composition, e.g. THC and CBD content), and should be free of contaminants (such as pesticides, heavy metals, fungi and bacteria, or other toxic compounds).
-the risks (side effects) versus benefits (therapeutic effects) should be studied in well designed clinical trials, especially for vulnerable patient groups such as the elderly, children, or immunocompromised patients. For palliative care, the use of cannabis products should be much easier.
How soon can we expect cannabis-based medicines in India?
India has a well-developed pharmaceutical industry, and some world-class research institutes. They are very well capable of turning Indian cannabis into medical products for the Indian and international market. If the development of these products is seriously supported (proper funding, easy access to permits, research institutes are interested), the first products could be available in 1-2 years. In order to play on the international stage, we have to consider quality standards such as ISO, GMP, FDA etc. Also, this may take more time because of the need to do more extensive clinical trials. In that case, we are probably looking at 3-5 years. It should be noted that some products, such as CBD-oil, may also be sold as a food supplement without extensive clinical testing.
What are the different medical applications of the non-narcotic component/cannabinoid of cannabis which is CBD, as opposed to the narcotic component/cannabinoid which is THC? Can these cannabinoids be individually extracted for medicinal use?
THC and CBD are both cannabinoids that are found in cannabis plants. However, they usually do not occur in the same plant. Rather, THC is found in marijuana type cannabis, while CBD is more prominent in hemp type cannabis. There are many more cannabinoids, such as CBG or THCV, which are also found in some varieties of cannabis. One of the tasks of cannabis researchers today is to find different cannabis varieties with unique cannabinoid content, for example from the Himalayas.
Cannabinoids can be isolated individually from cannabis varieties and mixed in any combination possible. CBD is a non-psychotropic cannabinoid that can be more easily used in medicine because it does not make you high. It seems to be very good for conditions where the nervous system is affected (epilepsy, anxiety, stress, alzheimer's etc.). THC is the famous psychotropic from cannabis that makes you feel high. However, it also has strong analgesic properties and can treat the symptoms of MS or chemotherapy. Because there are so many possible combinations possible of the cannabinoids, it is still difficult to say what cannabinoids are most optimal to treat specific diseases.
Studies can be done with whole cannabis plants (more holistic, all compounds are present) but also with extracts (only some compounds are present) or with the individual, single cannabinoids.
How conducive is the current Indian policy scenario/environment for accepting the medicinal use of cannabis? What are the lessons which can be learnt from medicinal cannabis policies of other nations for India?
Globally at the moment, Cannabis is an unknown territory for a lot of countries, but there are a handful of countries which have a very well organized regulatory framework for the introduction of Cannabis-based medicines in mainstream medicine or as an alternative medicine. These countries have created an access scheme for patients who are severely in need of these medications in the areas of Chronic pain, epilepsy, Multiple Sclerosis based symptom control and chemo therapy induced nausea and vomiting. In The Netherlands, for example, there is an overlooking administration called the Office of Medicinal Cannabis which is under the Dutch Ministry of Health which takes care of all activates with respect to Cannabis products and its utilization within the country as well as the import and export of medicinal cannabis in the event other countries require this material and have the required permits. Other countries have similar controlling bodies, that oversee the production, quality control and distribution of medicinal cannabis products. Examples are Italy, Germany, Australia and Canada.  
Cannabis has been intertwined with Indian history for over 1000 years. If the Indian Government can create the right framework for the medical use of cannabis in India, for conditions like chronic pain and for symptom management in other chronic and debilitating diseases like cancer which are on the rise in India, this could go a long way in helping these people. Not only has cannabis showcased promising results in that domain but also the fact that this plant was being used in our traditional medicine and now should be reintroduced as a modern medicine for the ailing masses.
So far, opiates have been the main drug of choice for many serious diseases, but opiates are rapidly losing their appeal. Like the example of the USA where due to overdosing of prescription opiates there are 91 deaths per day. If India can understand and learn from this situation and implement Cannabis-based medicines which are softer than opiates but highly effective medicines, nonetheless, India will not only generate revenue but also have a new research stream and a new industry as well to learn and apply. If done well, we could be global leaders in this space as the origins of the plant were in the lower Himalayas itself and its about time India restores the lost glory of one of the most sacred plants of our traditional medicine.
The environment for Cannabis-based medicine has improved over recent years as there has been a lot of focus on Cannabis globally. As a matter of fact, in 2015 India launched the Phytopharmaceutical Act of India which is focused on plant-based medicines but with a modern analytical approach to the same.
Along with that in 2016, Boheco held a conference at the Indian Habitat Centre which was focused on the medicinal benefits of cannabis, called the I-CARE (India Cannabis Analysis And Research) summit, where the Chief guest was the DCGI ( Drug Controller General of India). In his speech at I-CARE he said ‘’ Yes, we want to have a lenient approach rather than a restrictive approach. You people will be thinking and working together and as a regulator and technocrat, we are with you, till you are scientifically going to prove that you will protect the people of this country. We have already worked out the phytopharmaceutical path for new product development to be used for humanity and people of this country. You can use that platform. I see huge potential in these kinds of alternative medicines in the treatment of patients and people.” --
Dr. G N Singh
Drug Controller General of India 

Since then the first Medical Cannabis license has been granted by the Government for the cultivation of medically valuable Cannabis plants by the IIIM for use in the medicine sector. Hence there has been a shift in the Government towards making these medicines available In India and it is evident from the steps they have taken to introduce the same.

Once well regulated, medicinal cannabis can yield much needed new medicines, boost the pharmaceutical industry, and create new revenue. Countries that have introduced medicinal cannabis notice that the recreational use/abuse of cannabis does not seem to go up. Instead, the general public learns a lot from the discussion about medicinal use, and even recreational use can become less problematic.
Apart from traditional Vedic texts, are there references to cannabis in any other texts like Hriday Saar Sutra?
The earliest written reference to Cannabis in India may occur in the Atharvaveda, dating to about 1500 BCE [Russo 2005; Grierson 1894]. This ancient document hails the ‘bhang’ plant as one of the five sacred plants and as a source of happiness, donator of joy, and bringer of freedom [IDHC 1894]; “We tell of the five kingdoms of herbs headed by Soma; may it, and kusa grass, and bhang and barley, and the herb saha, release us from anxiety.”
In the Sushruta Samhita (meaning: the verses of Sushruta), dating from around 500 BCE, Cannabis was recommended for phlegm, catarrh, and diarrhoea. The Sushruta Samhita is among the most important ancient medical treatises, and one of the foundational texts of the medical tradition in India. The Rajanighantu, also known as Abhidhana Cudamani, is the famous work of Narahari Pandita, son of Iƛvarasuri, who was a resident of Kashmir around 1300 AD. The manuscript mentions Cannabis among various important medicinal plants. It states that “its effects on man are described as excitant, heating, astringent; it destroys phlegm, expels flatulence, induces costiveness, sharpens the memory, excites appetite, etc.”

Tix on sale for 5th annual NoCo Hemp Expo set for April 6-7 at The Ranch

Source: innovationews.com

noco-hemp-expo-5-logo

LOVELAND -- Tickets are now on sale for the 5th Annual  NoCo Hemp Expo, the largest two-day gathering of hemp thought leaders, speakers, producers, entrepreneurs, and exhibitors from around the globe.
Taking place April 6-7, 2018 at The Ranch Events Complex in Loveland, the event will showcase the latest products, innovations, research and advancements in the hemp industry world-wide, organizers said.  
Recognized by the Hemp Industries Association as the “Hemp Event of the Year,” NoCo5 will offer two interactive expo halls featuring products from international brands, introduce a Farm and Agriculture Symposium to share the latest research, techniques and methodologies for industrial hemp production, and an expanded hemp investment summit for the 5,500 attendees projected this year - an increase from 4,700 in 2017.
The trade show and conference is considered the most influential hemp-centric event in North America.
This year’s NoCo5 will draw professionals across industrial, nutritional and therapeutic hemp industries and feature attendance by state and federal government representatives spearheading current legislative changes around the future of hemp in the U.S. bringing increased media spotlights and attention on the future of the industry. 
With growing support across bipartisan lines, Congressman James Corner (R-KY), Bob Goodlatte (R-VA), Jared Polis (D-CO) and Thomas Massie (R-KY) joined forces to reintroduce the Industrial Hemp Farming Act in the summer of 2017 calling for the complete removal of hemp from its current oversight and regulations of the Controlled Substances Act. 
“Hemp has boundless potential as a sustainable alternative to plastics and other environmentally harmful products,” said Polis. 
“It’s past time that we eliminate absurd barriers and allow hemp farmers to get to work, create jobs, and grow this promising and historically important crop.” 
On Friday, April 6, NoCo5 will host “Industry B2B Day,” open to trade visitors and those interested in the hemp products market. Programming will feature the 3rd annual Hemp Summit, an important gathering of hemp-focused investors, founders and professionals.
In addition, Industry B2B Day attendees are invited to visit the exhibition halls, participate in interactive demonstrations, attend panels from over 75 industry experts and speakers, and learn the latest in new technologies, techniques, and applications.
For agricultural producers, a new, full-day NoCo5 Agricultural and Farm Symposium on April 7 will highlight early learnings, recommended production practices and market opportunities from pilot programs in Colorado, Kentucky, Pennsylvania and other states and regions where commercial hemp crops are permitted and/or licensed to be grown.
The symposium also will feature new equipment, recommended growing practices, and farming and agricultural exhibits. 
NoCo5’s two exhibition halls and educational seminars are open to the general public on April 7, where attendees will sample and experience the latest usage of natural industry hemp products, and attend panels and speaking events on the latest in environmental impacts, nutrition, and growing health and wellness applications.
In addition, the NoCo5 Global Hemp Village will showcase innovative products and ideas from international exhibitors, from super foods, supplements, textiles, paper, accessories, hemp beauty products, and plastic and building alternatives. 
“The cultural shift in the perceptions, demand, and applications for hemp in the U.S. and around the world are priming the hemp industries for growth, and NoCo5 is at the epicenter of the industrial hemp revolution” said president and NoCo Hemp Expo co-founder Morris Beegle. 
Tickets and registration are available for the general public, Industry B2B Day (including the Hemp Business Summit), and the Agricultural and Farm Symposium at http://nocohempexpo.com/ticket-sales/.
For speaker, sponsor, exhibitor and volunteer inquiries, visit http://nocohempexpo.com/registration-noco5/.